Advertisement

Is the Mannose-6-Phosphate/Insulin-Like Growth Factor 2 Receptor Coded by a Breast Cancer Suppressor Gene?

  • Guy Joseph Lemamy
  • Majida Esslimani Sahla
  • Marie Laurence Berthe
  • Pascal Roger
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 617)

Summary

The multifunctional growth factor mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2-R) binds proteins sharing M6P signals, including cathepsins and IGF2. It is involved in targeting newly synthesized mannose-6-phosphorylated lysosomal enzymes, activating transforming growth factor β (TGFβ), and neutralising the mitogen IGF2 by transporting it to lysosomes. The M6P/IGF2-R was proposed as being coded by a tumor suppressor gene. We measured gene expression at the protein level by quantitative immunohistochemistry, using chicken high affinity IgY antibodies directed against human M6P/IGF2-R. Chicken immunization was performed with human purified M6P/IGF2-R, and IgY antibodies were extracted from egg yolk by polyethylene glycol precipitation method. The biosensor analysis showed that IgY antibodies bind M6P/IGF2-R with high affinity (Kd = 7.5 nM). Quantitative immunohistochemical studies in sections from invasive breast carcinoma and ductal carcinoma in situ (DCIS) indicated various levels (from 5 to 400 units) of the M6P/IGF2-R protein, which did not correlate with tumor size, histological grade, estrogen and progesterone receptors. Moreover, the M6P/IGF2-R level was increased in DCIS relative to adjacent normal tissue (p < 0.005) and then decreased in invasive carcinoma compared with DCIS (p < 0.02). The hypothesis of tumor suppressor gene is not supported by these studies. However, it is not excluded for a small proportion of the tumors. Its assay might help to complement the cathepsin D assay to predict breast cancer prognosis and physiopathology.

Keywords

Invasive Breast Cancer Adjacent Normal Tissue Benign Breast Disease Invasive Breast Carcinoma Normal Lobule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Morgan DO, Edman JC, Standring DN, et al. (1987). Insulin-like growth factor 2 receptor as a multifunctional binding protein. Nature 329: 301–307.PubMedCrossRefGoogle Scholar
  2. 2.
    Dennis PA, Rifkin DB (1991). Cellular activation of latent transforming growth inhibitor β requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor 2 receptor. Proc. Natl. Acad. Sci. USA 88: 580–584.PubMedCrossRefGoogle Scholar
  3. 3.
    Rochefort H, Capony F, Garcia M, et al. (1987). Estrogen-induced lysosomal proteases secreted by breast cancer cells. A role in carcinogenesis. J. Cell Biochem. 35: 17–29.PubMedCrossRefGoogle Scholar
  4. 4.
    Capony F, Rougeot C, Montcourrier P, et al. (1989) Increased secretion altered processing and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res. 49: 3904–3909.PubMedGoogle Scholar
  5. 5.
    Laureys G, Barton GE, Ullrich A, et al. (1988). Chromosomal mapping of the gene for the type 2 Insulin-like growth factor/cation independent mannose-6-phosphate receptor in man and mouse. Genomics 3: 224–229.PubMedCrossRefGoogle Scholar
  6. 6.
    De Souza AT, Hankins GR, Washington MK, et al. (1995). M6P/IGF2-R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet. 11: 447–449.PubMedCrossRefGoogle Scholar
  7. 7.
    Chappel SA, Walsh T, Walker RA, et al. (1997). Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Brit. J. Cancer 75: 1324–1329.Google Scholar
  8. 8.
    Hankins GR, De Souza AT, Bentley RC, et al. (1996). M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12: 2003–2009.PubMedGoogle Scholar
  9. 9.
    Saito S, Sirahama S, Matsushima M, et al. (1996). Definition of commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27. Cancer Res. 56: 5586–5589.PubMedGoogle Scholar
  10. 10.
    Stuart CA, Pietrzyk RA, Furlanetto RW, et al. (1988). High affinity antibody from hen’s eggs directed against the human insulin receptor and the human IGF1 receptor. Anal. Biochem. 173: 142–150.PubMedCrossRefGoogle Scholar
  11. 11.
    Lemamy GJ, Roger P, Mani JC, et al. (1999). High-affinity antibodies from hen’s-egg yolks against human mannose-6-phosphate/Insulin-like growth factor 2 receptor (M6P/IGF2-R): characterization and potential use in clinical cancer studies. Int. J. Cancer 80: 896–902.PubMedCrossRefGoogle Scholar
  12. 12.
    Berthe ML, Esslimani Sahla M, Roger P, et al. (2003) Mannose-6-phosphate/Insulin-like growth factor 2 receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas. Eur. J. Cancer 39: 635–642.PubMedCrossRefGoogle Scholar
  13. 13.
    Maudelonde T, Brouillet JP, Roger P, et al. (1992). Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytolsolic assay. Eur. J. Cancer 28 A: 1686–1691.CrossRefGoogle Scholar
  14. 14.
    Yamada T, De Souza AT, Finkelstein S, et al. (1997). Loss of the gene encoding mannose-6-phosphate/inslin-like growth factor 2 receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. (Wash) 94: 10351–10355.PubMedCrossRefGoogle Scholar
  15. 15.
    Yashiro T, Tsushima T, Murakami H, et al. (1991). Insulin-like growth factor 2 (IGF2)/mannose-6-phosphate receptors are increased in primary human thyroid neoplasms. Eur. J. Cancer 27: 699–703.PubMedCrossRefGoogle Scholar
  16. 16.
    Hébert E, Herbelin C, Bougnoux P (1994). Analysis of the IGF2 receptor gene copy number in breast carcinoma. Br. J. Cancer 69: 120–124.PubMedGoogle Scholar
  17. 17.
    Zhao Y, Escot C, Maudelonde T, et al. (1993). Correlation between mannose-6-phosphate/IGF2 receptor and cathepsin D RNA levels by in situ hybridisation in benign and malignant mammary tumors. Cancer Res. 53: 2901–2905.PubMedGoogle Scholar
  18. 18.
    Confort C, Rochefort H, Vignon F (1995). Insulin-like growth factors (IGFs) stimulate the release of alpha 1- antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells. Endocrinology 136: 3759–3766.PubMedCrossRefGoogle Scholar
  19. 19.
    Mathieu M, Vignon F, Capony F, et al. (1991). Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor 2 receptor gene and induces cathepsin D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal pro-enzymes. Mol. Endocrinol. 5: 815–822.PubMedCrossRefGoogle Scholar
  20. 20.
    Rey JM, Theillet C, Brouillet JP, et al. (2000). Stable amino-acid sequence of the mannose-6-phosphate/Insulin-like growth factor 2 receptor in ovarian carcinomas with loss of heterozygosity in breast cancer cell lines. Int. J. Cancer 85: 466–473.PubMedCrossRefGoogle Scholar
  21. 21.
    Spyratos F, Brouillet JP, Defrenne A, et al. (1989). Cathepsin D: an independent prognostic factor for metastasis of breast cancer. The Lancet 11: 1115–1118.CrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Guy Joseph Lemamy
    • 1
  • Majida Esslimani Sahla
    • 2
  • Marie Laurence Berthe
  • Pascal Roger
    • 3
  1. 1.Faculte de MedecineUniversite des Sciences de la SanteLibreville (Central Africa)Gabon
  2. 2.Department of PathologieCRLC Val D’Aurelle ParcEuromedecineMontpellierFrance
  3. 3.Lab. D’Anatomie et Cytologie PatholHospital LapeyronieMontpellierFrance

Personalised recommendations